RETAPAMULIN
| Brand name | ALTABAX |
|---|---|
| Active ingredient | RETAPAMULIN |
| Strength | 1% |
| Dosage form | OINTMENT |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | April 2007 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 7875630 | February 2027 | substance |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.